Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndrome.
Journal: Brain, behavior, & immunity - health
Published: April 26, 2025
High-Frequency, At-Home Monitoring of Drug Safety and Tolerability in Clinical Trials: Results From Studies of Fluvoxamine for COVID-19 Treatment.
Journal: Clinical and translational science
Published: March 26, 2025
Diagnostic Criteria for Primary Tic Disorders: More Reappraisal.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: August 01, 2024
Author Correction: A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications.
Journal: Scientific reports
Published: July 22, 2024
Fluvoxamine and long COVID: Post-acute recovery.
Journal: Reviews in medical virology
Published: June 03, 2024
We've all been wrong about provisional tic disorder.
Journal: Comprehensive psychiatry
Published: April 30, 2024
A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications.
Journal: Scientific reports
Published: March 12, 2024
Sertraline modulates hippocampal plasticity and learning via sigma 1 receptors, cellular stress and neurosteroids.
Journal: bioRxiv : the preprint server for biology
Published: February 08, 2024
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial.
Journal: EClinicalMedicine
Published: September 21, 2023
Sertraline modulates hippocampal plasticity via sigma 1 receptors, cellular stress and neurosteroids.
Journal: Translational psychiatry
Published: August 18, 2023
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.
Journal: Open forum infectious diseases
Published: May 15, 2023
Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer.
Journal: The Journal of clinical psychiatry
Published: March 22, 2023
Last Updated: 09/26/2026